FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is the second most common malignancy in Europe and a leading cause of cancer-related death. Almost 50% of patients with CRC develop liver metastases, which heralds a poor prognosis unless metastases can be downsized to surgical resection or ablation. The FOXFIRE t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutton, Susan J, Kenealy, Nicola, Love, Sharon B, Wasan, Harpreet S, Sharma, Ricky A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107961/
https://www.ncbi.nlm.nih.gov/pubmed/25011439
http://dx.doi.org/10.1186/1471-2407-14-497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107961/
https://www.ncbi.nlm.nih.gov/pubmed/25011439
http://dx.doi.org/10.1186/1471-2407-14-497

Ejemplares similares